Oricell Therapeutics

Developer of immuno-therapeutics for cancer treatment

placePudong, Shanghai, China calendar_todayFounded 2015 groups150 employees language oricell.com

Social engagement

Social engagement: 2.9K social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

19 investors on record; lead investors include RTW Investments, Qatar Investment Authority, Qiming Venture Partners, Quan Capital.

Investor typeCountShare
Venture capital947%
Private equity737%
Other / undisclosed316%

Hiring activity

Hires occasionally

1 role tracked across 1 of the last 12 months

12 Dec 2025 · TCE Senior Scientist, Senior Scientist (In vivo CAR-T)

Based on job postings tracked across public sources.

Coming soon